Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report)’s stock price dropped 10.7% during mid-day trading on Tuesday . The company traded as low as $8.4050 and last traded at $8.4050. Approximately 350 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 1,383 shares. The stock had previously closed at $9.41.
Sumitomo Pharma Price Performance
The business has a 50 day moving average price of $9.76 and a 200 day moving average price of $12.28.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Further Reading
- Five stocks we like better than Sumitomo Pharma
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
